Alcon Inc. (ETR:2U3)
Germany · Delayed Price · Currency is EUR | Market Cap | 33.56B |
| Revenue (ttm) | 8.68B |
| Net Income (ttm) | 892.36M |
| Shares Out | n/a |
| EPS (ttm) | 1.79 |
| PE Ratio | 37.61 |
| Forward PE | 23.90 |
| Dividend | 0.30 (0.45%) |
| Ex-Dividend Date | May 13, 2025 |
| Volume | 1,190 |
| Average Volume | 1,385 |
| Open | 68.32 |
| Previous Close | 69.42 |
| Day's Range | 67.96 - 69.20 |
| 52-Week Range | 62.10 - 85.94 |
| Beta | 0.69 |
| RSI | 51.63 |
| Earnings Date | Feb 24, 2026 |
About Alcon
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ... [Read more]
Financial Performance
In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.
Financial numbers in USD Financial StatementsNews
Stifel Downgrades Alcon (ALC) and Lowers Target Price to $80.00 | ALC Stock News
Stifel Downgrades Alcon (ALC) and Lowers Target Price to $80.00 | ALC Stock News
STAAR Surgical holder Yunqi Capital purchased 750K shares for $21.53
Yunqi Capital buys 750K STAAR Surgical (STAA) shares after Alcon (ALC) cancels its acquisition.
Alcon terminates agreement to purchase STAAR Surgical
Alcon (ALC) Ends Merger with Staar Surgical; Focuses on Refractive Innovations
Alcon (ALC) Ends Merger with Staar Surgical; Focuses on Refractive Innovations
Alcon Terminates Agreement to Acquire STAAR Surgical
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today terminated its definitive merger agreement with STAAR Surgical Company (NASDAQ: STAA) announced ...
Alcon Terminates Agreement to Acquire STAAR Surgical
GENEVA--(BUSINESS WIRE)--Alcon Terminates Agreement to Acquire STAAR Surgical.
STAAR Surgical Merger With Alcon Fails After Shareholders Vote No
STAAR Surgical Company (NASDAQ: STAA) announced Tuesday that it did not receive the necessary stockholder votes to approve the merger agreement with Alcon Inc. (NYSE: ALC) at the Special Meeting of ...
STAAR Surgical Merger With Alcon Fails After Shareholders Vote No
STAAR Surgical Company (NASDAQ: STAA) announced Tuesday that it did not receive the necessary stockholder votes to approve the merger agreement with Alcon Inc. (NYSE: ALC) at the Special Meeting of St...
Alcon (ALC) Merger With Staar Surgical Fails to Secure Stockholder Approval
Alcon (ALC) Merger With Staar Surgical Fails to Secure Stockholder Approval
Alcon (ALC) Faces Uncertain Future After Failed Staar Surgical Deal
Alcon (ALC) Faces Uncertain Future After Failed Staar Surgical Deal
Alcon (ALC) Acquisition Proposal Rejected by STAAR Shareholders
Alcon (ALC) Acquisition Proposal Rejected by STAAR Shareholders
STAAR Surgical (STAA) Shares Drop 19% After Alcon Deal Termination
STAAR Surgical (STAA) Shares Drop 19% After Alcon Deal Termination
Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Compan...
Staar Surgical to reject Alcon takeover bid after failing to win shareholder backing
STAAR Surgical said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon after failing to secure enough shareholder votes to approve the deal, sending its shares down m...
STAAR Surgical sinks as it plans to terminate sale to Alcon
STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, announced that based on preliminar...
STAAR Surgical (STAA) Faces Potential Delay in Alcon (ALC) Acquisition Vote
STAAR Surgical (STAA) Faces Potential Delay in Alcon (ALC) Acquisition Vote
STAAR Surgical vote on Alcon may be delayed again - report
Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference
GENEVA--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST. A live web...
Alcon (ALC) Faces Opposition in STAAR Surgical Acquisition
Alcon (ALC) Faces Opposition in STAAR Surgical Acquisition
Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Compan...
STAAR Surgical (STAA) Rises Amid Adjourned Shareholder Vote on Alcon Deal
STAAR Surgical (STAA) Rises Amid Adjourned Shareholder Vote on Alcon Deal
Alcon (ALC) Postpones Special Meeting to January 2026
Alcon (ALC) Postpones Special Meeting to January 2026
STAAR Surgical gains as special meeting on Alcon deal is adjourned
Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right...